Study on the Pharmacological Mechanism of Icariin for the Treatment of Alzheimer’s Disease Based on Network Pharmacology and Molecular Docking Techniques
Open Access
- 19 December 2023
- journal article
- research article
- Published by MDPI AG in Metabolites
- Vol. 14 (1) , 1
Abstract
The purpose of this study is to explore the pharmacological mechanism of icariin (ICA) in the treatment of Alzheimer’s disease (AD) based on network pharmacology and network molecular docking technology. In order to investigate the regulatory effect of ICA on the expression level of AD pathological phosphorylation regulatory proteins, this study further explored the possible molecular mechanism of ICA regulating AD autophagy through network pharmacology. Macromolecular docking network was verified by Autodock Vina 1.1.2 software. The main active ingredients of ICA, the physicochemical properties, and pharmacokinetic information of ICA were predicted using online databases and relevant information. The results showed that the targets of MAPK3, AKT1, HSP90AA1, ESR1, and HSP90AA1 were more critical in the treatment of AD. Autophagy, apoptosis, senescence factors, phosphatidylinositide 3-kinase/protein kinase B (P13K/AKT) signaling pathway, MAKP, mTOR, and other pathways were significantly associated with AD. Docking of ICA with HIF-1, BNIP3, PINK1, and Parkin pathway molecules showed that the key targets of the signaling pathway were more stably bound to ICA, which may provide a better pathway for ICA to regulate autophagy by providing a better pathway. ICA can improve AD, and its mechanism may be related to the P13K/AKT, MAKP, and mTOR signaling pathways, thereby regulating autophagy-related proteins.Keywords
Funding Information
- Liaoning provincial department of education (JYTMS/20231403)
This publication has 59 references indexed in Scilit:
- Alzheimer's disease: Targeting the Cholinergic SystemCurrent Neuropharmacology, 2016
- Dose-specific effect of simvastatin on hypoxia-induced HIF-1α and BACE expression in Alzheimer’s disease cybrid cellsBMC Neurology, 2015
- Immune attack: the role of inflammation in Alzheimer diseaseNature Reviews Neuroscience, 2015
- Innate immunity in Alzheimer's diseaseNature Immunology, 2015
- The dendritic hypothesis for Alzheimer's disease pathophysiologyBrain Research Bulletin, 2014
- Effect of Vitamin E and Memantine on Functional Decline in Alzheimer DiseaseJAMA, 2014
- Current and future treatments for Alzheimer’s diseaseTherapeutic Advances in Neurological Disorders, 2012
- Microtubule Affinity-regulating Kinase 2 (MARK2) Turns on Phosphatase and Tensin Homolog (PTEN)-induced Kinase 1 (PINK1) at Thr-313, a Mutation Site in Parkinson DiseaseJournal of Biological Chemistry, 2012
- Molecular mechanisms of neurodegeneration in Alzheimer's diseaseHuman Molecular Genetics, 2010
- Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trialThe Lancet, 2004